(HealthDay)—New evidence shows that depression and anxiety are increasing as a result of the COVID-19 pandemic, according to the results of a survey released by Mental Health America (MHA).
Jul 8, 2020
0
15
Restricting access to high-risk medications via a real-time prescription monitoring program such as Victoria's SafeScript may help reduce inappropriate use, but integrated mental health and drug treatment services may be ...
Jun 22, 2020
0
2
The coronavirus pandemic is taking its toll on Americans' mental health, with more than 88,000 people developing anxiety or depression as a result, according to Mental Health America (MHA), a U.S. community-based nonprofit ...
Jun 3, 2020
0
12
Led by King's College London in collaboration with the University of Zimbabwe and the London School of Hygiene & Tropical Medicine, and published in The Lancet's EClinicalMedicine journal, the research examined a group of ...
May 27, 2020
0
153
Acne treatment including the highly effective acne medication isotretinoin should be made more readily available despite reports of its association with depression and teen suicide. That's the implication of a study just ...
Mar 16, 2020
0
4
Patients with depression, anxiety or stress are more likely to drop out of cardiac rehabilitation, reports a study published on World Mental Health Day in the European Journal of Preventive Cardiology, a journal of the European ...
Oct 10, 2019
0
5
A researcher from the University of Houston has found that adults who take prescription opioids for severe pain are more likely to have increased anxiety, depression and substance abuse issues if they also use marijuana.
Aug 12, 2019
0
5
Accoording a recent study, schizophrenia is considered an illness by nearly all Finns, while grief and homosexuality are not. On the other hand, opinions vary greatly on whether alcoholism, work exhaustion, drug addiction ...
Jun 6, 2019
0
13
(HealthDay)—Acupressure is associated with improvements in co-occurring symptoms in breast cancer survivors with fatigue, according to a study recently published in JNCI Cancer Spectrum.
Mar 13, 2019
0
4
The FDA recently approved a ketamine-based drug to assist with treating depression. The new medication, Spravato, is an intranasal spray that can help those suffering with extreme depression who see little results with psychiatric ...
Mar 13, 2019
0
31
